Literature DB >> 8501788

The influence of age, parity, oral contraception, hysterectomy and menopause on the prevalence of urinary incontinence in women.

I Milsom1, P Ekelund, U Molander, L Arvidsson, B Areskoug.   

Abstract

The influence of age, parity, duration of previous oral contraceptive use, hysterectomy and menopause on the prevalence of urinary incontinence was evaluated by means of a postal questionnaire in women 46 to 86 years old who resided in the city of Göteborg, Sweden. A sample of 10,000 women from the 7 birth cohorts of 1900 to 1940 was obtained at random from the population register. The overall response rate was 74.6%. The prevalence of urinary incontinence increased (p < 0.001) in a linear fashion from 12.1% in the 1940 birth cohort to 24.6% in the 1900 birth cohort. The prevalence of urinary incontinence in nulliparous women was 7.7% in the 1930 birth cohort and 5.5% in the 1940 birth cohort. The corresponding figures for women who had experienced 1 delivery were 11.1% and 10.6%, compared to 14.0% and 16.4% among women who had had 3 or more deliveries. Urinary incontinence was more prevalent in women who had undergone hysterectomy (p < 0.05). The prevalence of urinary incontinence was unaffected by the duration of previous oral contraceptive use and there was no evidence to suggest that the prevalence of urinary incontinence increased at the time of the last menstrual period.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8501788     DOI: 10.1016/s0022-5347(17)36415-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  35 in total

1.  Can we predict and prevent pelvic floor dysfunction?

Authors:  Ian Milsom
Journal:  Int Urogynecol J       Date:  2015-12       Impact factor: 2.894

2.  Incidence and remission rates of lower urinary tract symptoms at one year in women aged 40-60: longitudinal study.

Authors:  L A Møller; G Lose; T Jørgensen
Journal:  BMJ       Date:  2000-05-27

3.  Mode of delivery and severe stress incontinence. a cross-sectional study among 2,625 perimenopausal women.

Authors:  Xavier Fritel; Virginie Ringa; Noëlle Varnoux; Arnaud Fauconnier; Stéphanie Piault; Gérard Bréart
Journal:  BJOG       Date:  2005-12       Impact factor: 6.531

4.  IGF-1 gene-modified muscle-derived stem cells are resistant to oxidative stress via enhanced activation of IGF-1R/PI3K/AKT signaling and secretion of VEGF.

Authors:  Chunjing Chen; Ying Xu; Yanfeng Song
Journal:  Mol Cell Biochem       Date:  2013-10-15       Impact factor: 3.396

5.  The cost of urinary incontinence in Italian women. A cross-sectional study. Gruppo di Studio Incontinenza.

Authors:  F Tediosi; F Parazzini; A Bortolotti; L Garattini
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

6.  Oral contraceptive use and incident urinary incontinence in premenopausal women.

Authors:  Mary K Townsend; Gary C Curhan; Neil M Resnick; Francine Grodstein
Journal:  J Urol       Date:  2009-03-17       Impact factor: 7.450

Review 7.  Desensitization of bladder sensory fibers by intravesical capsaicin or capsaicin analogs. A new strategy for treatment of urge incontinence in patients with spinal detrusor hyperreflexia or bladder hypersensitivity disorders.

Authors:  F Cruz
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

8.  Urinary symptoms and impact on quality of life in women after treatment for endometrial cancer.

Authors:  E A Erekson; V W Sung; P A DiSilvestro; D L Myers
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-11-05

9.  Assessment of menopausal symptoms using modified Menopause Rating Scale (MRS) among middle age women in Kuching, Sarawak, Malaysia.

Authors:  Syed Alwi Syed Abdul Rahman; Siti Rubiah Zainudin; Verna Lee Kar Mun
Journal:  Asia Pac Fam Med       Date:  2010-02-22

Review 10.  Rational prescribing for postmenopausal urogenital complaints.

Authors:  I Milsom
Journal:  Drugs Aging       Date:  1996-08       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.